Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats

Bone

Volumn 58, Issue , 2014, Pages 168-176

  Meng, Yan ^a,b,c,d   Zhang, Hao ^e   Li, Yingbin ^e   Zuo, Li ^a,b,c,d   Li, Qingnan ^e  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b PEKING UNIVERSITY   (China)

^c BEIJING HOSPITAL   (China)

^d Ministry of Education   (China)

^e GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Chronic kidney disease; Renal osteodystrophy; Secondary hyperparathyroidism; Unfractionated heparin; Vascular calcification

Indexed keywords

ADENINE; CALCIUM; CREATININE; FIBROBLAST GROWTH FACTOR 23; HEPARIN; NITROGEN; PARATHYROID HORMONE; PHOSPHORUS; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL CALCIFICATION; BONE DENSITY; BONE MASS; CALCIUM BLOOD LEVEL; CELL ACTIVITY; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CORTICAL BONE; DRUG MEGADOSE; FEMUR; HYPERPARATHYROIDISM; LOW DRUG DOSE; MALE; MINERAL METABOLISM; MORPHOMETRICS; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; RAT; RENAL OSTEODYSTROPHY; TRABECULAR BONE; UREA NITROGEN BLOOD LEVEL;

BFR/BS; BFR/BV; BLOOD UREA NITROGEN; BMD; BONE FORMATION RATE (BONE AREA REFERENT); BONE FORMATION RATE (BONE SURFACE REFERENT); BONE MINERAL DENSITY; BUN; CHRONIC KIDNEY DISEASE; CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER; CKD; CKD-MBD; CORTICAL BONE AREA (POROSITY AREA REDUCED); CT.B.AR; DUAL-ENERGY X-RAY ABSORPTIOMETRY; DXA; ELISA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FGF-23; FIBROBLAST GROWTH FACTOR-23; GPWI; GROWTH PLATE WIDTH; H-UFH; HIGH-DOSE UNFRACTIONATED HEPARIN; ICP-OES; INDUCTIVELY COUPLED PLASMA OPTICAL EMISSION SPECTROMETER; KDIGO; KIDNEY DISEASE: IMPROVING GLOBAL OUTCOMES; L-UFH; LGR; LONGITUDINAL GROWTH RATE; LOW-DOSE UNFRACTIONATED HEPARIN; MAR; MINERAL APPOSITION RATE; MINERALIZATION LAG TIME; MLT; N.OB/BS; N.OC/BS; OB.S/BS; OC.S/BS; OS/BS; OSTEOBLAST NUMBER PER MILLIMETER BONE PERIMETER; OSTEOBLAST SURFACE; OSTEOCLAST NUMBER PER MILLIMETER BONE PERIMETER; OSTEOCLAST SURFACE; OSTEOID SURFACE; OSTEOID VOLUME; OV/BV; PARATHYROID HORMONE; PO.AR; PO.AR%; POROSITY AREA; POROSITY AREA PERCENT; PRIMARY BV/TV; PRIMARY SPONGIOSA BONE VOLUME; PTH; QCT; QUANTITATIVE COMPUTED TOMOGRAPHY; REGION OF INTEREST; RENAL OSTEODYSTROPHY; ROI; SECONDARY BV/TV; SECONDARY HYPERPARATHYROIDISM; SECONDARY SPONGIOSA BONE VOLUME; SINGLE PHOTON ABSORPTIOMETRY; SPA; TB.N; TB.SP; TB.TH; TRABECULAR NUMBER; TRABECULAR SEPARATION; TRABECULAR THICKNESS; UFH; UNFRACTIONATED HEPARIN; VASCULAR CALCIFICATION;

ANIMALS; AORTA; BODY WEIGHT; BONE DENSITY; DENSITOMETRY; DISEASE MODELS, ANIMAL; FEMUR; HEPARIN; MALE; PHOSPHORUS; RATS; RATS, SPRAGUE-DAWLEY; RENAL INSUFFICIENCY, CHRONIC; RENAL OSTEODYSTROPHY; VASCULAR CALCIFICATION;

EID: 84887360292     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2013.10.010     Document Type: Article

References (40)

1. Collins A.J., Foley R.N., Chavers B., Gilbertson D., Herzog C., Johansen K., et al. United States Renal Data System 2011 Annual Data Report: atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis 2012, 59(A7). e1-e420.
2. Cameron J.S. Practical haemodialysis began with cellophane and heparin: the crucial role of William Thalhimer (1884-1961). Nephrol Dial Transplant 2000, 15:1086-1091.
3. Cronin R.E., Reilly R.F. Unfractionated heparin for hemodialysis: still the best option. Semin Dial 2010, 23:510-515.
4. Brunet P., Simon N., Opris A., Faure V., Lorec-Penet A.M., Portugal H., et al. Pharmacodynamics of unfractionated heparin during and after a hemodialysis session. Am J Kidney Dis 2008, 51:789-795.
5. Griffith G.C., Nichols G., Asher J.D., Flanagan B. Heparin osteoporosis. JAMA 1965, 193:91-94.
6. Mutoh S., Takeshita N., Yoshino T., Yamaguchi I. Characterization of heparin-induced osteopenia in rats. Endocrinology 1993, 133:2743-2748.
7. Muir J.M., Andrew M., Hirsh J., Weitz J.I., Young E., Deschamps P., et al. Histomorphometric analysis of the effects of standard heparin on trabecular bone in vivo. Blood 1996, 88:1314-1320.
8. Monreal M., Lafoz E., Olive A., del Rio L., Vedia C. Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin. Thromb Haemost 1994, 71:7-11.
9. Matzsch T., Bergqvist D., Hedner U., Nilsson B., Ostergaard P. Heparin-induced osteoporosis in rats. Thromb Haemost 1986, 56:293-294.
10. Douketis J.D., Ginsberg J.S., Burrows R.F., Duku E.K., Webber C.E., Brill-Edwards P. The effects of long-term heparin therapy during pregnancy on bone density. A prospective matched cohort study. Thromb Haemost 1996, 75:254-257.
11. Dahlman T.C. Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin. Am J Obstet Gynecol 1993, 168:1265-1270.
12. Hak A.E., Pols H.A., van Hemert A.M., Hofman A., Witteman J.C. Progression of aortic calcification is associated with metacarpal bone loss during menopause: a population-based longitudinal study. Arterioscler Thromb Vasc Biol 2000, 20:1926-1931.
13. Choi S.H., An J.H., Lim S., Koo B.K., Park S.E., Chang H.J., et al. Lower bone mineral density is associated with higher coronary calcification and coronary plaque burdens by multidetector row coronary computed tomography in pre- and postmenopausal women. Clin Endocrinol (Oxf) 2009, 71:644-651.
14. London G.M., Marty C., Marchais S.J., Guerin A.P., Metivier F., de Vernejoul M.C. Arterial calcifications and bone histomorphometry in end-stage renal disease. J Am Soc Nephrol 2004, 15:1943-1951.
15. Braun J., Oldendorf M., Moshage W., Heidler R., Zeitler E., Luft F.C. Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis 1996, 27:394-401.
16. Bucay N., Sarosi I., Dunstan C.R., Morony S., Tarpley J., Capparelli C., et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 1998, 12:1260-1268.
17. Moe S.M., Drueke T.B., Cunningham J., Goodman W., Martin K., Olgaard K., et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2006, 69:1945-1953.
18. Yokozawa T., Zheng P.D., Oura H., Koizumi F. Animal model of adenine-induced chronic renal failure in rats. Nephron 1986, 44:230-234.
19. Okada H., Kaneko Y., Yawata T., Uyama H., Ozono S., Motomiya Y., et al. Reversibility of adenine-induced renal failure in rats. Clin Exp Nephrol 1999, 3:82-88.
20. Reeves P.G., Nielsen F.H., Fahey G.C. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993, 123:1939-1951.
21. Neven E., Dauwe S., De Broe M.E., D'Haese P.C., Persy V. Endochondral bone formation is involved in media calcification in rats and in men. Kidney Int 2007, 72:574-581.
22. Parfitt A.M., Drezner M.K., Glorieux F.H., Kanis J.A., Malluche H., Meunier P.J., et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 1987, 2:595-610.
23. Moe S.M., Chen N.X., Seifert M.F., Sinders R.M., Duan D., Chen X., et al. A rat model of chronic kidney disease-mineral bone disorder. Kidney Int 2009, 75:176-184.
24. Jarvinen T.L., Sievanen H., Kannus P., Jarvinen M. Dual-energy X-ray absorptiometry in predicting mechanical characteristics of rat femur. Bone 1998, 22:551-558.
25. Neven E., Persy V., Dauwe S., De Schutter T., De Broe M.E., D'Haese P.C. Chondrocyte rather than osteoblast conversion of vascular cells underlies medial calcification in uremic rats. Arterioscler Thromb Vasc Biol 2010, 30:1741-1750.
26. Pasch A., Schaffner T., Huynh-Do U., Frey B.M., Frey F.J., Farese S. Sodium thiosulfate prevents vascular calcifications in uremic rats. Kidney Int 2008, 74:1444-1453.
27. Henderson R.G., Russell R.G., Earnshaw M.J., Ledingham J.G., Oliver D.O., Woods C.G. Loss of metacarpal and iliac bone in chronic renal failure: influence of haemodialysis, parathyroid activity, type of renal disease, physical activity and heparin consumption. Clin Sci (Lond) 1979, 56:317-324.
28. Taal M.W., Masud T., Green D., Cassidy M.J. Risk factors for reduced bone density in haemodialysis patients. Nephrol Dial Transplant 1999, 14:1922-1928.
29. Stein M.S., Packham D.K., Ebeling P.R., Wark J.D., Becker G.J. Prevalence and risk factors for osteopenia in dialysis patients. Am J Kidney Dis 1996, 28:515-522.
30. Binici D.N., Gunes N. Risk factors leading to reduced bone mineral density in hemodialysis patients with metabolic syndrome. Ren Fail 2010, 32:469-474.
31. KDIGO CKD-MBD Work Group KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int 2009, 76:S1-S130.
32. Lewis M., Shaw J., Reid C., Evans J., Webb N., Verrier-Jones K. Growth in children with established renal failure-a Registry analysis. Nephrol Dial Transplant 2007, 22(Suppl. 7):vii176-vii180. (chapter 14).
33. Seikaly M.G., Salhab N., Gipson D., Yiu V., Stablein D. Stature in children with chronic kidney disease: analysis of NAPRTCS database. Pediatr Nephrol 2006, 21:793-799.
34. Kock H.J., Handschin A.E. Osteoblast growth inhibition by unfractionated heparin and by low molecular weight heparins: an in-vitro investigation. Clin Appl Thromb Hemost 2002, 8:251-255.
35. Fuller K., Chambers T.J., Gallagher A.C. Heparin augments osteoclast resorption-stimulating activity in serum. J Cell Physiol 1991, 147:208-214.
36. Chowdhury M.H., Hamada C., Dempster D.W. Effects of heparin on osteoclast activity. J Bone Miner Res 1992, 7:771-777.
37. Yang L., Butcher M., Simon R.R., Osip S.L., Shaughnessy S.G. The effect of heparin on osteoblast differentiation and activity in primary cultures of bovine aortic smooth muscle cells. Atherosclerosis 2005, 179:79-86.
38. Moe S.M., Chen N.X. Mechanisms of vascular calcification in chronic kidney disease. J Am Soc Nephrol 2008, 19:213-216.
39. Hadjidakis D.J., Androulakis I.I. Bone remodeling. Ann N Y Acad Sci 2006, 1092:385-396.
40. Tanaka Y., Nakayamada S., Okada Y. Osteoblasts and osteoclasts in bone remodeling and inflammation. Curr Drug Targets Inflamm Allergy 2005, 4:325-328.